Unidad de Investigación, Hospital Galdakao-Usansolo, Barrio Labeaga S/N, 48960, Galdakao, Vizcaya, Spain.
Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Barakaldo, Vizcaya, Spain.
Intern Emerg Med. 2022 Aug;17(5):1481-1490. doi: 10.1007/s11739-022-02948-4. Epub 2022 Feb 28.
COPD readmissions have a great impact on patients' quality of life and mortality. Our goal was to identify factors related to 60-day readmission. We conducted a prospective observational cohort study with a nested case-control study, with 60 days of follow-up after the index admission. Patients readmitted were matched, by age, baseline forced expiratory volume in 1 s and month at admission, with patients admitted in the same period but not readmitted at 2 months. Data were collected on sociodemographic and clinical characteristics and health-related quality of life data at the index admission and events from discharge to readmission within 60 days. Conditional logistic (60-day readmission) and Cox (days to readmission) regression models were constructed. Both multivariable analyses identified the following as predictors: any admission in the preceding 2 months (OR: 2.366; HR: 1.918), hematocrit at ED arrival ≤ 35% (OR: 2.949; HR: 1.570), pre-existing cardiovascular disease (valvular disease or myocardial infarction) (OR: 1.878; HR: 1.490); NIMV at discharge (OR: 0.547; HR: 0.70); no appointment with a specialist after discharge (OR: 5.785; HR: 3.373) and patient-reported need for help at home (OR: 2.978; HR: 2.061). The AUC for the logistic model was 0.845 and the c-index for the Cox model was 0.707. EuroQol EQ-5D score before the admission was correlated with a lower risk of readmission (OR: 0.383; HR: 0.670). As conclusions, we have identified factors related to 60-day readmission and summarized the findings in easy-to-use scoring scales that could be incorporated into the daily clinical routine and may help establish preventive measures to reduce future readmissions.Registration: Clinical Trial Registration NCT03227211.
COPD 再入院对患者的生活质量和死亡率有重大影响。我们的目标是确定与 60 天再入院相关的因素。我们进行了一项前瞻性观察队列研究,其中嵌套了病例对照研究,在指数入院后进行了 60 天的随访。再入院患者按年龄、基线 1 秒用力呼气量和入院月份与同期入院但在 2 个月内未再入院的患者相匹配。在指数入院时收集社会人口统计学和临床特征以及与健康相关的生活质量数据,并收集出院至 60 天内再入院的事件数据。构建了条件逻辑(60 天再入院)和 Cox(再入院天数)回归模型。多变量分析均确定以下因素为预测因素:前 2 个月内任何一次入院(OR:2.366;HR:1.918)、急诊到达时的血细胞比容 ≤ 35%(OR:2.949;HR:1.570)、预先存在的心血管疾病(瓣膜病或心肌梗死)(OR:1.878;HR:1.490);出院时接受无创通气(OR:0.547;HR:0.70);出院后未预约专科医生(OR:5.785;HR:3.373)和患者自述在家需要帮助(OR:2.978;HR:2.061)。逻辑模型的 AUC 为 0.845,Cox 模型的 C 指数为 0.707。入院前的 EuroQol EQ-5D 评分与较低的再入院风险相关(OR:0.383;HR:0.670)。结论:我们确定了与 60 天再入院相关的因素,并总结了易于使用的评分量表中的发现,这些发现可纳入日常临床实践,并有助于制定预防措施以减少未来的再入院。注册:临床试验注册 NCT03227211。